A. Aimon

2.3k citations

23 papers · 1.8k · 1 hit paper · h-index 16

Impact in

Computational Theory and Mathematics top 1%
- Computational Drug Discovery Methods
Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies

Papers in

Computational Theory and Mathematics 9
- Computational Drug Discovery Methods 9
Organic Chemistry 10
- Organic Chemistry Synthesis Methods 4
- Asymmetric Synthesis and Catalysis 3
- Advanced Synthetic Organic Chemistry 3
- Cyclopropane Reaction Mechanisms 1

Co-authors: Frank von Delft (6 shared papers)Adam S. Nelson (6 shared papers)R. Skyner (2 shared papers)A. Douangamath (2 shared papers)Louise E. Dunnett (2 shared papers)D. Fearon (2 shared papers)T.J. Gorrie-Stone (2 shared papers)J. Brandão-Neto (2 shared papers)
Journals: Nature Communications (2 papers)Angewandte Chemie International Edition (2 papers)Science Advances (1 paper)Molecules (1 paper)Cell stem cell (1 paper)
Partner nations: United Kingdom South Africa United States

In The Last Decade

A. Aimon

23 papers receiving 1.7k citations

A. Aimon's Hit Papers

align trajectories log scale

Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors 2023 · 126 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2023 Science

Peers

Countries citing papers authored by A. Aimon

Since Specialization

Citations

This map shows the geographic impact of A. Aimon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Aimon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Aimon more than expected).

Fields of papers citing papers by A. Aimon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Aimon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Aimon. The network helps show where A. Aimon may publish in the future.

Co-authors

The 25 scholars most cited alongside A. Aimon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A. Aimon Line = papers co-authored together A. Aimon links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease Nature Communications ·A. Douangamath, D. Fearon, Paul Gehrtz, Tobias J. Krojer, Petra Lukacik, Callum D. Owen, Efrat Resnick, Claire M. Strain-Damerell	2020	436
2	Rapid Covalent-Probe Discovery by Electrophile-Fragment Screening Journal of the American Chemical Society ·Efrat Resnick, Anthony R Bradley, Jinrui Gan, A. Douangamath, Tobias J. Krojer, Ritika Sethi, Paul P. Geurink, A. Aimon	2019	265
3	SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids Cell stem cell ·Jitske Jansen, Katharina C. Reimer, James Shiniti Nagai, Finny S. Varghese, Gijs J. Overheul, Marit A. de Beer, Rona Roverts, Deniz Daviran	2021	197
4	Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase Nature Communications ·Joseph A. Newman, A. Douangamath, Setayesh Yazdani, Y. Yosaatmadja, A. Aimon, J. Brandão-Neto, Louise E. Dunnett, T.J. Gorrie-Stone	2021	194
5	Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking Science Advances ·Marion Schuller, G.J. Correy, Stefan Gahbauer, D. Fearon, Taiasean Wu, Roberto Efraín Díaz, I.D. Young, Luan Carvalho Martins	2021	146
6	Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors Science ·Melissa L. Boby, John D. Chodera, Alpha A. Lee, Nir London, Annette von Delft, Frank von Delft, Hagit Achdout, A. Aimon Hit paper breakdown →	2023	126
7	Organocatalytic Synthesis of Highly Substituted Furfuryl Alcohols and Amines Angewandte Chemie International Edition ·J. Stephen Clark, Alistair Boyer, A. Aimon, Paloma E. Garcia, David M. Lindsay, Andrew D. F. Symington, Yves Danoy	2012	75
8	Synthesis and Demonstration of the Biological Relevance of sp3‐rich Scaffolds Distantly Related to Natural Product Frameworks Chemistry - A European Journal ·Daniel J. Foley, Philip G. E. Craven, P.M. Collins, Richard G. Doveston, A. Aimon, Romain Talon, Ian Churcher, Adam S. Nelson +2 others	2017	54
9	Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source Journal of Visualized Experiments ·A. Douangamath, A.J. Powell, D. Fearon, P.M. Collins, Romain Talon, Tobias J. Krojer, R. Skyner, J. Brandão-Neto	2021	53
10	Activity‐Directed Synthesis with Intermolecular Reactions: Development of a Fragment into a Range of Androgen Receptor Agonists Angewandte Chemie International Edition ·George Karageorgis, Mark Dow, A. Aimon, Stuart L. Warriner, Adam S. Nelson	2015	39
11	Design, synthesis and decoration of molecular scaffolds for exploitation in the production of alkaloid-like libraries Bioorganic & Medicinal Chemistry ·Philip G. E. Craven, A. Aimon, Mark Dow, Nicolas Fleury‐Brégeot, Rachel Guilleux, Rémy Morgentin, Didier Roche, Tuomo Kalliokoski	2014	30
12	Accelerating Drug Discovery With High‐Throughput Crystallographic Fragment Screening and Structural Enablement Applied Research ·D. Fearon, A.J. Powell, A. Douangamath, Alexandre M.M. Dias, Charles W.E. Tomlinson, Blake H. Balcomb, Jasmin Cara Aschenbrenner, A. Aimon	2024	24
13	SAMPL7 protein-ligand challenge: A community-wide evaluation of computational methods against fragment screening and pose-prediction Journal of Computer-Aided Molecular Design ·Harold Grosjean, Mehtap Işık, A. Aimon, David L. Mobley, John D. Chodera, Frank von Delft, Philip Charles Biggin	2022	23
14	Turning high-throughput structural biology into predictive inhibitor design Proceedings of the National Academy of Sciences ·Kadi Liis Saar, William McCorkindale, D. Fearon, Melissa L. Boby, Haim Michael Barr, Amir Ben‐Shmuel, Nir London, Frank von Delft	2023	23
15	Rapid optimisation of fragments and hits to lead compounds from screening of crude reaction mixtures Communications Chemistry ·Lisa M. Baker, A. Aimon, James B. Murray, Allan E. Surgenor, Natalia Matassova, Stephen D. Roughley, P.M. Collins, Tobias J. Krojer	2020	20
16	Demonstration of the utility of DOS-derived fragment libraries for rapid hit derivatisation in a multidirectional fashion Chemical Science ·Sarah L. Kidd, Elaine Fowler, Till Reinhardt, Natalia Mateu, Hector Newman, Dom Bellini, Romain Talon, Joseph McLoughlin	2020	17
17	Realisation of small molecule libraries based on frameworks distantly related to natural products Organic & Biomolecular Chemistry ·A. Aimon, George Karageorgis, Jacob Masters, Mark Dow, Philip G. E. Craven, Martin Ohsten Rasmussen, Anthony Willaume, Rémy Morgentin	2018	15
18	Translation of innovative chemistry into screening libraries: an exemplar partnership from the European Lead Factory Drug Discovery Today ·Rémy Morgentin, Mark Dow, A. Aimon, George Karageorgis, Tuomo Kalliokoski, Didier Roche, Stephen P. Marsden, Adam S. Nelson	2018	13
19	Robotic Catalysis: A High‐Throughput Method for Miniature Screening of Mesoporous Metal Oxides** Chemistry - Methods ·Kariska Potgieter, A. Aimon, Elize Smit, Frank von Delft, Reinout Meijboom	2020	10
20	Expanding the Repertoire of Low‐Molecular‐Weight Pentafluorosulfanyl‐Substituted Scaffolds ChemMedChem ·Arathy Jose, Daniel Guest, Rémi Legay, Graham John Tizzard, Simon John Coles, Mariliza Derveni, Edward Wright, Lester Marrison	2022	10

About A. Aimon

A. Aimon is a scholar working on Computational Theory and Mathematics, Organic Chemistry, Infectious Diseases, Materials Chemistry and Molecular Biology, having authored 23 papers that have together received 1.8k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (9 papers), Chemical Synthesis and Analysis (7 papers), Enzyme Structure and Function (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Organic Chemistry Synthesis Methods (4 papers), Asymmetric Synthesis and Catalysis (3 papers), Advanced Synthetic Organic Chemistry (3 papers) and Cyclopropane Reaction Mechanisms (1 paper). The work is most often cited by research in Computational Theory and Mathematics (566 citations), Infectious Diseases (513 citations), Organic Chemistry (391 citations), Molecular Biology (485 citations) and Nephrology (51 citations). A. Aimon has collaborated with scholars based in United Kingdom, South Africa and United States. Frequent co-authors include Frank von Delft, Adam S. Nelson, R. Skyner, A. Douangamath, Louise E. Dunnett, D. Fearon, T.J. Gorrie-Stone, J. Brandão-Neto, O. Gileadi and Joseph A. Newman. Their work appears in journals such as Nature Communications, Angewandte Chemie International Edition, Science Advances, Molecules and Cell stem cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

A. Aimon

Impact in

Papers in i

In The Last Decade

A. Aimon

A. Aimon's Hit Papers

Peers

Countries citing papers authored by A. Aimon

Fields of papers citing papers by A. Aimon

All Works

About A. Aimon

Explore authors with similar magnitude of impact

Papers in